CHALKIS(000972)
Search documents
中基健康(000972) - 2018 Q3 - 季度财报
2018-10-30 16:00
Financial Performance - Operating revenue for the current period was CNY 101,822,430.00, a decrease of 46.86% year-on-year[9] - Net profit attributable to shareholders was a loss of CNY 33,374,719.87, with a year-to-date loss of CNY 117,220,861.77[9] - Basic earnings per share for the current period was -0.0433 CNY, with a year-to-date figure of -0.1520 CNY[9] - Weighted average return on net assets was -4.25%, a decrease of 18.36 percentage points year-on-year[9] - Net profit attributable to shareholders of the parent company was a loss of ¥117,220,861.77, a decrease of 246.71% compared to the previous year[18] - Basic earnings per share dropped by 246.72% to -0.1520 due to increased losses[18] - Total operating revenue for the current period is ¥101,822,430, a decrease of 47% from ¥191,611,687.47 in the previous period[40] - Net profit for the current period is -¥32,642,270.56, compared to a net profit of ¥192,598,098.44 in the previous period, indicating a significant decline[41] - The company reported a gross loss of ¥31,859,402.95 for the current period, worsening from a loss of ¥25,371,450.52 in the previous period[41] - Total comprehensive income for the current period is -¥29,307,373.94, compared to ¥191,727,228.44 in the previous period[41] - Operating profit for the current period is -¥3,973,724.90, a decline from ¥22,308,551.89 in the previous period[42] - The net profit for Q3 2018 was -121,580,443.13 CNY, compared to a profit of 151,228,278.96 CNY in the same period last year, indicating a significant decline[46] - The company reported a comprehensive income total of -130,996,067.52 CNY for Q3 2018, down from 152,540,238.96 CNY in the same quarter last year[46] Asset and Liability Changes - Total assets decreased by 29.83% to CNY 1,715,869,991.36 compared to the end of the previous year[9] - Net assets attributable to shareholders decreased by 13.99% to CNY 758,926,840.92 compared to the end of the previous year[9] - Cash and cash equivalents decreased by 71.75% to ¥34,953,797.60 due to repayment of loans and accounts payable[18] - Inventory decreased by 34.90% to ¥586,497,529.29 as a result of product sales[18] - Long-term equity investments decreased by 100% to ¥0 due to the consolidation of Tianjin Zhongchen Can Co., Ltd.[18] - Total liabilities decreased from CNY 1,560,278,681.93 to CNY 961,814,888.37, a decrease of about 38.3%[35] - The total equity attributable to shareholders decreased from CNY 882,362,014.79 to CNY 758,926,840.92, a decline of about 14%[35] - Current assets decreased from CNY 1,273,721,025.17 to CNY 722,357,492.64, a reduction of about 43.3%[33] - The non-current assets decreased from CNY 1,171,608,827.28 to CNY 993,512,498.72, a reduction of approximately 15.2%[33] Cash Flow Analysis - Cash flow from operating activities for the year-to-date was CNY 173,961,072.91[9] - Cash received from tax refunds decreased by 46.95% to ¥26,640,018.37 due to reduced export tax rebates[19] - Cash paid for purchasing goods and services decreased by 48.01% to ¥255,705,730.11 due to reduced production[19] - Cash received from borrowings decreased by 64.26% to ¥89,000,000.00 compared to the previous year[19] - Cash inflow from operating activities totaled ¥23,567,966.49, a decrease of 46.8% from ¥44,338,981.78 in the previous period[55] - Cash outflow from operating activities increased significantly to ¥20,675,401.53, compared to ¥8,972,056.94 in the previous period, marking a rise of 130.5%[55] - The total cash outflow from financing activities was -262,268,494.93 CNY, compared to a net inflow of 6,514,243.61 CNY in the previous year, indicating a shift towards higher cash outflows[53] - The company received 89,000,000.00 CNY in borrowings during the period, compared to 249,000,000.00 CNY in the previous year, showing a decrease in new debt financing[53] Operational Costs - Operating costs increased by 35.43% to ¥435,788,547.30 driven by increased sales volume of bulk tomato sauce[18] - Total operating costs for the current period are ¥134,028,284.48, down 38.5% from ¥216,983,137.99 in the previous period[40] - The company incurred management expenses of 10,043,426.21 CNY, slightly higher than 9,793,756.59 CNY in the previous year, reflecting increased operational costs[49] - Financial expenses for the current period are ¥25,986,071.41, a decrease from ¥28,444,190.63 in the previous period[44] - The financial expenses for the period were 3,968,503.93 CNY, down from 4,270,777.44 CNY in the previous year, indicating a reduction in financing costs[49] Shareholder Information - The company reported no significant changes in shareholder structure during the reporting period[14] - There were no preferred shareholders as of the end of the reporting period[15] Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report[58] - The third quarter report has not been audited, which may affect the reliability of the financial data presented[58]
中基健康(000972) - 2018 Q2 - 季度财报
2018-08-24 16:00
Financial Performance - The company's operating revenue for the first half of 2018 was ¥336,010,975.33, representing a 90.95% increase compared to ¥175,970,904.72 in the same period last year[19]. - The net profit attributable to shareholders of the listed company was -¥83,846,141.90, compared to -¥40,068,245.37 in the previous year, indicating a significant loss[19]. - The net cash flow from operating activities increased by 109.01% to ¥67,745,581.37 from ¥32,412,535.80 year-on-year[19]. - The basic earnings per share were -¥0.1087, compared to -¥0.0520 in the same period last year[19]. - The weighted average return on net assets was -9.98%, a decrease of 5.04 percentage points compared to -4.94% in the previous year[19]. - The net profit attributable to shareholders was -¥83,846,141.90, worsening the loss by ¥43,777,896.53 year-on-year[31]. - The operating costs rose to ¥335,932,957.78, a 124.15% increase year-on-year, primarily due to increased sales volume of large-pack tomato sauce[35]. - The gross profit margin for the manufacturing sector decreased by 14.88% year-on-year, attributed to a prolonged market downturn and low sales prices[37]. - The net loss for the period was CNY 88,938,172.57, compared to a net loss of CNY 41,369,519.48 in the previous year, indicating a worsening financial performance[146]. Assets and Liabilities - Total assets decreased by 23.47% to ¥1,871,493,130.15 from ¥2,445,329,852.45 at the end of the previous year[19]. - The net assets attributable to shareholders of the listed company decreased by 10.46% to ¥790,100,529.02 from ¥882,362,014.79 at the end of the previous year[19]. - The company’s total assets and net assets are expected to significantly improve following the acquisition of Taihe Biochemical, enhancing profitability and asset quality[32]. - The total liabilities decreased from CNY 1,560,278,681.93 to CNY 1,088,130,653.22, showing a reduction in the company's debt levels[139]. - The total equity attributable to shareholders decreased from CNY 882,362,014.79 to CNY 790,100,529.02, indicating a decline in shareholder value[139]. Cash Flow - The company’s cash and cash equivalents decreased by ¥60,090,593.07, compared to a decrease of ¥14,487,464.32 in the previous year[35]. - The cash and cash equivalents at the end of the period amount to 63,658,051.30, down from 175,818,082.15 in the previous period, indicating a decrease of approximately 63.70%[153]. - The net cash flow from operating activities is 67,745,581.37, an increase from 32,412,535.80 in the previous period, showing a growth of about 108.67%[152]. - The total cash outflow from financing activities was 54,449,041.67, resulting in a net cash flow from financing activities of -34,449,041.67[156]. Strategic Plans and Acquisitions - The company plans to acquire 100% equity of Taihe Biochemical through a share issuance, aiming to enhance its dual main business structure in tomato and citric acid industries[32]. - The company plans to dispose of certain subsidiary equity to optimize resource allocation and improve asset structure[33]. - The company plans to continue optimizing its tomato product structure, focusing on the development and promotion of high-value-added tomato health products and beverages[58]. Legal and Compliance Issues - The company has faced risks related to weather conditions affecting tomato production and high market competition in the tomato sauce industry[56]. - The company has been involved in multiple legal disputes with MasterCard and Zhongchen Cans regarding contract violations and payment defaults[77]. - Zhongji Health has faced significant legal challenges, including multiple lawsuits related to contract breaches and financial obligations[80]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 46,298[119]. - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 15.46% of the shares[119]. - There were no changes in the controlling shareholder or actual controller during the reporting period[122]. Corporate Governance - The company has not engaged in any derivative investments or sold any significant assets or equity during the reporting period[49][50][51]. - The financial report for the half-year period was not audited[134]. - The integrity status of the company and its controlling shareholders is good, with no unfulfilled court judgments or significant overdue debts[91]. Operational Highlights - The company operates in the food processing industry, with a focus on health and medical technology investments[174]. - The company has established wastewater treatment facilities that meet discharge standards, with a treatment capacity of 450m3/H[108]. - The company has entered into a lease agreement for a total area of 60,000 square meters of land and 36,900 square meters of factory space for 8 years[102].
中基健康(000972) - 2018 Q1 - 季度财报
2018-04-27 16:00
Financial Performance - The company's revenue for Q1 2018 was ¥47,328,180.62, representing a decrease of 31.30% compared to ¥68,892,620.64 in the same period last year[8] - The net profit attributable to shareholders was -¥9,981,246.45, an improvement from -¥20,725,628.91 year-on-year[8] - The net cash flow from operating activities decreased by 61.35% to ¥6,407,367.83 from ¥16,578,893.39 in the previous year[8] - Operating revenue fell by 31.30% to ¥47,328,180.62, primarily due to a decline in sales volume of large-pack tomato sauce[16] - Operating costs decreased by 48.52% to ¥33,007,693.23, reflecting the drop in sales volume of large-pack tomato sauce[16] Assets and Shareholder Information - The total assets at the end of the reporting period were ¥2,337,542,096.39, down 4.41% from ¥2,445,329,852.45 at the end of the previous year[8] - The net assets attributable to shareholders decreased by 1.20% to ¥871,791,318.16 from ¥882,362,014.79 at the end of the previous year[8] - The total number of ordinary shareholders at the end of the reporting period was 47,386[11] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., held 15.46% of shares, totaling 119,243,804 shares[11] Cash Flow and Expenses - Cash and cash equivalents decreased by 42.71% to ¥70,896,003.65 due to repayment of loans and accounts payable[16] - Accounts payable decreased by 36.27% to ¥247,745,818.82 as a result of repayment of payables[16] - Financial expenses increased by 51.36% to ¥11,427,856.76, attributed to exchange rate fluctuations and increased borrowing costs[16] - Cash received from tax refunds rose by 39.53% to ¥13,171,869.85, driven by an increase in export tax rebates[16] - Cash paid for purchasing goods and services increased by 33.46% to ¥168,644,399.21 due to higher accounts payable payments[16] - Cash paid for debt repayment increased by 96.96% to ¥100,000,000.00, reflecting a rise in matured loans compared to the previous year[16] Non-Recurring Items and Strategic Changes - The company reported a total of ¥353,574.80 in non-recurring gains and losses during the reporting period[9] - There were no significant changes in the company's strategy or new product developments mentioned in the report[15] - The company did not report any significant events or changes in commitments during the reporting period[17][18] - There were no derivative investments during the reporting period[22] Return on Net Assets - The weighted average return on net assets improved to -1.14%, up by 1.38 percentage points from -2.52% year-on-year[8]
中基健康(000972) - 2017 Q4 - 年度财报
2018-03-22 16:00
Financial Performance - The company's operating revenue for 2017 was ¥517,710,604.78, a decrease of 11.98% compared to ¥588,176,013.79 in 2016[18]. - The net profit attributable to shareholders in 2017 was ¥36,689,853.12, a significant recovery from a loss of ¥254,111,462.52 in 2016[18]. - Basic earnings per share for 2017 were ¥0.05, compared to a loss of ¥0.33 per share in 2016[18]. - The total assets at the end of 2017 were ¥2,445,329,852.45, reflecting a 1.36% increase from ¥2,412,637,151.91 at the end of 2016[18]. - The net assets attributable to shareholders increased by 6.07% to ¥882,362,014.79 at the end of 2017, up from ¥831,844,874.38 in 2016[18]. - The weighted average return on net assets improved to 4.28% in 2017, a rise of 30.76 percentage points from -26.48% in 2016[18]. - The company achieved total revenue of ¥517,710,604.78, a decrease of 11.98% compared to ¥588,176,013.79 in the previous year[37]. - The net profit attributable to the parent company was ¥36,689,853.12, with net assets of ¥882,362,014.79[37]. - The manufacturing sector contributed ¥499,536,660.99, accounting for 96.49% of total revenue, down 12.36% from the previous year[43]. - The company reported a net profit for the 2017 fiscal year, reversing the negative net profit trend of the previous two years[92]. Cash Flow and Financial Management - The net cash flow from operating activities was -¥176,181,920.66, an improvement from -¥206,922,771.39 in the previous year[18]. - The company has faced challenges in cash flow management, as indicated by the negative cash flow from operating activities[18]. - The total cash inflow from financing activities increased by 35.93% to ¥1,029,000,000.00 in 2017, compared to ¥756,980,000.00 in 2016[57]. - The total amount of cash and cash equivalents decreased to ¥123,748,644.37, accounting for 5.06% of total assets, down from 9.24% in 2016[59]. - The company reported a net cash flow from operating activities of -¥176,181,920.66 in 2017, an improvement from -¥206,922,771.39 in 2016[57]. Market and Product Development - In Q1 2023, the company reported revenue of approximately ¥68.89 million, which increased to ¥517.71 million by Q4 2023, showing a significant growth trend[22]. - The company has established a seed company to control the source of tomato processing, aiming to improve the quality and yield of tomato varieties[31]. - The company has invested in 110 harvesting machines, which can reduce labor costs by 40%-60% compared to manual harvesting, enhancing efficiency and quality[32]. - The company’s "ChalkiS" brand tomato sauce has been recognized as a key product supported by the Ministry of Commerce, indicating strong market positioning[27]. - The company plans to enhance market marketing and cost management to improve the financial status of the tomato industry[28]. - The company aims to optimize its tomato product structure, focusing on the development and promotion of tomato health cosmetics and beverages, as well as high-value tomato lycopene health products[78]. Challenges and Risks - The company faced high production costs and weak profitability due to industry overcapacity and low international market prices[39]. - The company reported a 22.55% decrease in sales volume of bulk tomato sauce, with inventory levels increasing by 44%[47]. - The company faces risks related to weather conditions affecting tomato yield and quality, as well as high concentration in its tomato sauce product line and reliance on exports[79]. - The company has made efforts in business transformation, including raw material base construction and mechanical harvesting, but profitability remains low[75]. Governance and Compliance - The company continues to strengthen its governance structure by integrating party organization roles into its corporate governance framework[37]. - The company has not experienced any changes in the scope of consolidated financial statements compared to the previous year[90]. - The company has engaged Zhongxing Cai Guanghua Accounting Firm for audit services, with a fee of 1 million yuan for the current period[91]. - The company has not faced any penalties from securities regulatory agencies in the past three years[164]. - The company has maintained a complete and independent governance structure, ensuring no significant differences from regulatory requirements[173]. Shareholding and Ownership - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., holds 15.46% of the shares, totaling 119,243,804 shares[138]. - The second largest shareholder, Xinjiang Wujiaqu Urban Construction Investment Co., Ltd., holds 12.97% of the shares, totaling 100,000,000 shares[138]. - The company has no significant changes in shareholding structure or major events during the reporting period[131]. - The total number of shareholders at the end of the reporting period was 49,943, an increase from 48,545 at the previous month-end[138]. Social Responsibility and Community Engagement - The company is recognized as a key agricultural industrialization leading enterprise and has contributed significantly to the economic development of Xinjiang[124]. - The company has created over 4,000 long-term fixed employment opportunities and provided 8,000 seasonal job opportunities annually in rural areas[126]. - The company actively promotes energy conservation and environmental protection in its operations[125]. - The company is committed to integrating social responsibility with its development strategy and regularly evaluates its social responsibility practices[128].
中基健康(000972) - 2017 Q2 - 季度财报(更新)
2017-11-06 16:00
Financial Performance - The company's operating revenue for the first half of 2017 was ¥175,970,904.72, representing a 1.58% increase compared to ¥173,239,674.47 in the same period last year[19]. - The net profit attributable to shareholders was -¥40,068,245.37, an improvement from -¥54,720,007.25 in the previous year[19]. - The net cash flow from operating activities was ¥32,412,535.80, a significant recovery from -¥163,088,887.18 in the same period last year[19]. - The basic earnings per share improved to -¥0.0520 from -¥0.0709 in the same period last year[19]. - The weighted average return on net assets increased to -4.94%, up by 0.22 percentage points from -5.16% in the previous year[19]. - Operating costs decreased by 7.02% to ¥149,872,074.14, contributing to improved cost management[34]. - The gross profit margin for the manufacturing sector was 16.36%, an increase of 7.73% compared to the previous year[36]. - The company reported a significant increase in income tax expenses by 4,514.75% due to government subsidies being recognized as taxable income[34]. - The company reported a continuous net profit loss for the past two years, raising concerns about potential delisting risks if losses persist[56]. - The company reported a net profit loss of CNY 7,315,944.51 from its subsidiary Tianjin Zhongchen Tomato Products Co., Ltd., which had an operating income of CNY 45,550,814.45[52]. Assets and Liabilities - The total assets decreased by 10.28% to ¥2,164,727,299.71 from ¥2,412,637,151.91 at the end of the previous year[19]. - The net assets attributable to shareholders decreased by 4.55% to ¥793,959,459.01 from ¥831,844,874.38 at the end of the previous year[19]. - The company's cash and cash equivalents increased to ¥181,818,760.52, up from ¥109,640,709.67, representing a 3.63% increase in total asset proportion[39]. - The total current assets amounted to CNY 980,872,147.42, down from CNY 1,180,141,702.95, indicating a decline of approximately 16.91%[134]. - The total liabilities decreased to CNY 1,443,634,935.94 from CNY 1,652,358,098.66, a decline of approximately 12.61%[135]. - The total equity attributable to shareholders of the parent company was CNY 793,959,459.01, down from CNY 831,844,874.38, reflecting a decrease of about 4.55%[136]. - The company's total assets were CNY 2,164,727,299.71, down from CNY 2,412,637,151.91, indicating a decline of approximately 10.26%[136]. Corporate Governance and Compliance - The company plans not to distribute cash dividends or issue bonus shares for the year[6]. - There were no significant changes in the company's core business or major assets during the reporting period[25][26]. - The company has not engaged in derivative investments or sold significant assets or equity during the reporting period[48][49][50]. - The semi-annual report of the company was not audited[66]. - There were no bankruptcy reorganization matters during the reporting period[70]. - The company faced 65 civil lawsuits from investors due to false statements, with a total claim amount of approximately RMB 21,249,617.19[71]. - The court ruled to dismiss 23 investor lawsuits, involving a total amount of RMB 10,035,232.12[72]. - The company is involved in a lease contract dispute with Master Packaging Co., with claims for management fees, profit shares, and other compensations totaling RMB 67,877,894.95[74]. - The company has appealed against the first-instance judgment in the lease dispute case, which is currently under review by the Tianjin High People's Court[75]. - The company and its controlling shareholders have a good integrity status, with no significant overdue payments reported[82]. Strategic Initiatives - The company plans to establish a tomato industry fund with Xinjiang Kunlun Stone Equity Investment Management Co., Ltd. to invest in the tomato industry chain[32]. - A merger fund is being initiated with Hunan Jialian Asset Management Co., Ltd. to focus on investments and acquisitions in the health industry[32]. - The company aims to enhance its capital market financing and restructuring efforts to enter the high-growth health industry[59]. - The company plans to optimize its product structure by focusing on high-value tomato health drinks and lycopene health products[59]. - The company plans to strengthen its raw material base and improve cost efficiency across all stages of tomato production and processing[58]. Shareholder Information - The total number of shares remains at 771,283,579, with no changes during the reporting period[111]. - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 15.46% of shares, totaling 119,243,804 shares[115]. - Xinjiang Wujiaqu Urban Construction Investment Co., Ltd. holds 12.97% of shares, totaling 100,000,000 shares[115]. - Total number of common shareholders at the end of the reporting period is 56,224[115]. Environmental and Social Responsibility - The company employs over 4,000 long-term fixed job opportunities, contributing to local economic growth[102]. - The company has not reported any significant environmental protection issues during the reporting period[106]. - The company has not initiated any targeted poverty alleviation work during the reporting period and has no subsequent plans[100][105]. Financial Reporting and Accounting - The financial statements are prepared based on the assumption of going concern and comply with the relevant accounting standards[179]. - The company has no significant uncertainties affecting its ability to continue as a going concern within the next 12 months[180]. - The company follows the accrual basis of accounting, except for certain financial instruments[179]. - The accounting period for the company is based on the calendar year, from January 1 to December 31[182]. - The company uses Renminbi as its functional currency for accounting purposes[183].
中基健康(000972) - 2017 Q3 - 季度财报
2017-10-26 16:00
Financial Performance - Operating revenue for the reporting period was ¥191,611,687.47, representing a year-on-year increase of 38.44%[8] - Net profit attributable to shareholders of the listed company was ¥119,969,759.43, with a year-to-date increase of 17.95% to ¥367,582,592.19[8] - Basic earnings per share for the reporting period was ¥0.1556, compared to ¥0.1036 in the same period last year[8] - Net profit attributable to shareholders of the parent company reached ¥79,901,514.06, a 187.56% increase due to profitability this year[16] Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,453,934,892.32, an increase of 1.71% compared to the previous year[8] - Net assets attributable to shareholders of the listed company increased by 9.76% to ¥913,058,348.44[8] - Cash and cash equivalents decreased by 40.26% to ¥133,235,643.14 due to various payments made during the period[16] - Deferred income tax liabilities increased by 71.05% to ¥1,052,819.18, resulting from changes in the value of available-for-sale financial assets[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 51,738[11] - The top shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of shares[11] Operational Activities - The company reported a net cash flow from operating activities of -¥94,598,104.02 year-to-date[8] - Prepayments increased by 118.15% to ¥33,961,142.50, primarily for purchasing packaging materials during production[16] - Inventory rose by 39.38% to ¥893,820,284.49, attributed to the addition of new products[16] - Operating income from non-operating activities surged by 3,698.35% to ¥225,654,969.31, driven by increased debt waiver income[16] Financial Changes - Non-recurring gains and losses totaled ¥223,973,808.95, primarily from debt restructuring gains of ¥224,463,455.92[9] - The company reported a 676.74% increase in business tax and additional fees, totaling ¥4,725,829.24, due to changes in accounting[16] - Financial expenses rose by 47.84% to ¥28,444,190.63, mainly due to exchange rate fluctuations[16] - The company received cash from investments amounting to ¥1,024,180.57, marking a 100% increase as this business did not occur in the previous year[16] Commitments and Matters - The company has no significant matters or commitments that were not fulfilled during the reporting period[17][18]
中基健康(000972) - 2017 Q2 - 季度财报
2017-08-18 16:00
Financial Performance - The company's operating revenue for the first half of 2017 was ¥175,970,904.72, representing a 1.58% increase compared to ¥173,239,674.47 in the same period last year[19]. - The net profit attributable to shareholders was -¥40,068,245.37, an improvement from -¥54,720,007.25 in the previous year[19]. - The net cash flow from operating activities was ¥32,412,535.80, a significant recovery from -¥163,088,887.18 in the same period last year[19]. - The basic earnings per share for the first half of 2017 was -¥0.0520, an improvement from -¥0.0709 in the same period last year[19]. - The weighted average return on net assets was -4.94%, a slight increase of 0.22 percentage points from -5.16% in the previous year[19]. - Operating costs decreased by 7.02% to ¥149,872,074.14, contributing to improved cost management[34]. - The gross profit margin for the manufacturing sector was 16.36%, an increase of 7.73% compared to the previous year[36]. - The company reported a net profit loss of CNY 20,631,825.69 from its subsidiary Xinjiang Zhongji Red Tomato Industry Co., Ltd.[52]. - The net profit for the current period is CNY -41,369,519.48, an improvement from CNY -58,251,231.04 in the previous period, representing a reduction in loss of approximately 29.0%[144]. - The total comprehensive income for the current period is CNY -39,186,689.48, compared to CNY -59,285,719.04 in the previous period, indicating a significant improvement[144]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,164,727,299.71, down 10.28% from ¥2,412,637,151.91 at the end of the previous year[19]. - The net assets attributable to shareholders decreased by 4.55% to ¥793,959,459.01 from ¥831,844,874.38 at the end of the previous year[19]. - The company's total liabilities decreased to CNY 1,443,634,935.94 from CNY 1,652,358,098.66, showing a reduction of about 12.59%[135]. - The company's total non-current assets decreased to CNY 1,183,855,152.29 from CNY 1,232,495,448.96, indicating a decrease of about 3.95%[134]. - The company's total equity decreased to CNY 721,092,363.77 from CNY 760,279,053.25, reflecting a decline of approximately 5.15%[136]. - The company's cash and cash equivalents decreased from 223,025,602.47 RMB to 181,818,760.52 RMB, a decline of approximately 18.5%[133]. - Accounts receivable decreased from 183,234,415.05 RMB to 115,849,511.47 RMB, a decline of approximately 36.7%[133]. - Inventory decreased from 641,284,635.88 RMB to 592,570,592.94 RMB, a decline of approximately 7.6%[133]. - The total amount of retained earnings decreased by CNY 9,673,861.30 compared to the previous period[170]. Cash Flow - The operating cash flow net amount is CNY 32,412,535.80, a turnaround from CNY -163,088,887.18 in the previous period[150]. - The net cash flow from financing activities was -45,911,734.31 CNY, a decrease from -58,464,103.06 CNY in the previous period, indicating a reduction in cash outflow[151]. - The cash inflow from operating activities totaled 40,402,669.83 CNY, compared to 9,395,618.54 CNY in the previous period, showing a substantial increase[152]. - The cash outflow for purchasing goods and services was 1,763,602.78 CNY, down from 3,413,485.93 CNY in the previous period, indicating cost control measures[152]. Business Operations - The company plans to establish a tomato industry fund with Xinjiang Kunlun Stone Investment Management Co., Ltd. to invest in the tomato industry chain[32]. - A merger fund is being initiated with Hunan Jialian Asset Management Co., Ltd. to focus on investments and acquisitions in the health industry[32]. - The company plans to enhance its tomato product structure by developing and promoting high-value tomato health drinks and lycopene health products[59]. - The company aims to reduce costs and improve efficiency across all stages of its tomato production and processing operations[58]. - The company operates in the food processing industry, with business activities including investment in health and medical technology industries, project investment, and asset management consulting[176]. Legal and Compliance Issues - The company faced 65 civil lawsuits from investors due to false statements, with a total claim amount of approximately RMB 21,249,617.19[71]. - The court ruled to dismiss 23 investor lawsuits, involving a total amount of RMB 10,035,232.12[71]. - The company is involved in a lease contract dispute with Master Packaging, claiming a total compensation of RMB 67,877,894.95[74]. - The company has appealed against the first-instance judgment regarding the lease contract dispute, and the case is currently under review by the Tianjin High Court[75]. - The company has not reported any major environmental issues or significant matters requiring explanation during the reporting period[106][107]. Corporate Governance - The company has not distributed cash dividends or increased share capital during the reporting period[64]. - There were no significant guarantees provided by the company to external parties during the reporting period[95]. - The company approved a total guarantee amount of CNY 70 million during the reporting period, with an actual guarantee amount of CNY 10 million[97]. - The company and its controlling shareholders have a good integrity status, with no significant overdue payments reported[82]. - The company has not engaged in any significant related party transactions during the reporting period[84]. Future Outlook - The company anticipates a continued net profit loss for the year, which may lead to a risk of delisting if the negative trend persists[55]. - The company has faced risks related to weather conditions affecting tomato production and a high concentration in its product offerings[56]. - The company has not initiated any targeted poverty alleviation work during the reporting period and has no subsequent plans[100][105].
中基健康(000972) - 2017 Q1 - 季度财报
2017-04-28 16:00
Financial Performance - The company's revenue for Q1 2017 was ¥68,892,620.64, a decrease of 38.53% compared to ¥112,072,369.04 in the same period last year[8] - The net profit attributable to shareholders was -¥20,725,628.91, an improvement from -¥22,442,614.68 year-on-year[8] - The net cash flow from operating activities was ¥16,578,893.39, a significant recovery from -¥210,993,620.99 in the previous year[8] - Revenue declined by 38.53% to ¥68,892,620.64, primarily due to a significant drop in sales volume of small packaged products[16] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,239,574,886.38, down 7.17% from ¥2,412,637,151.91 at the end of the previous year[8] - The net assets attributable to shareholders decreased by 2.27% to ¥812,977,101.47 from ¥831,844,874.38 at the end of the previous year[8] - Accounts receivable decreased by 37.43% to ¥114,646,905.96 due to increased collection efforts[16] - Prepayments decreased by 65.89% to ¥19,433,744.73 as products were sold, reducing advance payments[16] - Cash paid for purchasing goods and services decreased by 59.12% to ¥126,359,190.32 due to a reduction in accounts payable[16] - Cash paid for debt repayment increased by 396.18% to ¥50,772,800.00, reflecting repayment of bank loans[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 63,507[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of the shares[11] - There were no preferred shareholders during the reporting period[13] Operational Efficiency - The weighted average return on net assets improved by 0.23 percentage points to -2.52% from -2.75% year-on-year[8] - Management expenses reduced by 39.79% to ¥11,160,810.27, attributed to lower salary and depreciation expenses[16] Government Support and Events - The company received government subsidies amounting to ¥121,739.73 during the reporting period[9] - The company reported no significant events during the reporting period[17] - There were no violations of external guarantees or non-operating fund occupation by controlling shareholders[25][26] Other Comprehensive Income - Other comprehensive income fell by 100.62% to ¥3,704,353.54 due to a decline in stock prices[16] - Cash received from loans was zero, indicating no new loans were obtained during the period[16]
中基健康(000972) - 2016 Q4 - 年度财报
2017-04-14 16:00
Financial Performance - The company reported consecutive net losses for 2015 and 2016, leading to a "delisting risk warning" from the Shenzhen Stock Exchange[6]. - The company plans to not distribute cash dividends or issue bonus shares for the year[6]. - The company's operating revenue for 2016 was ¥588,176,013.79, a decrease of 13.87% compared to ¥682,896,707.47 in 2015[18]. - The net profit attributable to shareholders for 2016 was -¥254,111,462.52, compared to -¥48,308,582.78 in 2015, indicating a significant loss[18]. - The net cash flow from operating activities for 2016 was -¥206,922,771.39, worsening from -¥38,448,076.69 in 2015[18]. - The total assets at the end of 2016 were ¥2,412,637,151.91, down 8.26% from ¥2,629,834,559.20 at the end of 2015[19]. - The net assets attributable to shareholders decreased by 23.51% to ¥831,737,536.97 in 2016 from ¥1,087,440,444.08 in 2015[19]. - The company reported a weighted average return on equity of -26.48% in 2016, a decline of 10.97 percentage points from -15.51% in 2015[18]. - The company’s stock will face suspension if the net profit or net assets remain negative for the fiscal year 2017[6]. - The company reported a net profit of -26,867.22 million, with a net profit attributable to shareholders of -25,411.15 million, indicating a significant loss[103]. Business Strategy and Operations - The company aims to leverage the "Belt and Road" and "Healthy China" national strategies to transform and upgrade its operations[16]. - The company is focusing on capital operations and mergers and acquisitions to enhance its market position in the health industry[16]. - The company aims to continue consolidating and developing its "red industry" while exploring the health industry for future growth[30]. - The company is focusing on developing high-value-added tomato products, including health drinks and lycopene health products[90]. - The company plans to enhance its raw material base and mechanization in tomato planting and harvesting to reduce costs and improve efficiency[89]. - The company is pursuing mergers and acquisitions to expand its business in the health industry and create new profit growth points[90]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market reach[182]. - The company has a strategic plan to increase shareholder value through potential mergers and acquisitions in the health industry[173]. Challenges and Risks - The company faced severe challenges including overcapacity in the domestic tomato sauce industry and low international market prices, leading to significant operational pressure[38]. - The tomato supply instability due to factors like planting area and climate has led to underutilization of production capacity[86]. - The company is facing challenges in upgrading its main business due to a lack of high-quality tomato varieties and advanced planting technology[86]. - The long-term outlook for the tomato sauce industry remains pessimistic, with low added value and limited market capacity posing significant challenges[87]. - The company has experienced consecutive years of negative net profit for 2015 and 2016, risking delisting if it does not achieve positive results in 2017[92]. Corporate Governance and Compliance - The company has engaged Zhongxing Caiguanghua Accounting Firm to audit its financial reports, which received an unqualified opinion with emphasis on certain matters[5]. - The company has not changed its accounting policies, estimates, or methods during the reporting period[111]. - The company has not experienced any significant accounting errors requiring restatement during the reporting period[112]. - The integrity status of the company and its controlling shareholders is good, with no unfulfilled court judgments or significant overdue debts[127]. - The company has established a comprehensive corporate governance structure in compliance with relevant laws and regulations, ensuring no significant discrepancies with the requirements set by the China Securities Regulatory Commission[198]. Human Resources and Employment - The company employed a total of 1,123 staff, with 455 in production, 32 in sales, and 274 in technical roles[191]. - The total remuneration for directors, supervisors, and senior management in 2016 amounted to 1.8672 million yuan (including tax) for 21 individuals[188]. - The company has established a transparent performance evaluation and incentive mechanism for employee remuneration[193]. - The company has no labor outsourcing situations reported during the period[195]. - The company has created over 4,000 long-term fixed employment opportunities and provides 8,000 seasonal job opportunities annually in rural areas of Xinjiang, Inner Mongolia, and Gansu[146]. Environmental and Social Responsibility - The company emphasizes energy conservation and environmental protection, implementing policies to improve energy utilization and wastewater treatment capabilities[145]. - The company has established a comprehensive environmental protection policy tailored to the seasonal production of tomato sauce[145]. - The company actively supports poverty alleviation by donating goods and providing assistance to families in need[147]. - The company has helped over 200,000 local farmers increase their income through tomato cultivation, contributing to regional economic growth[146]. Market and Product Development - The company is focusing on expanding its market presence and enhancing its product offerings through new technology development[173]. - The company plans to enhance its digital marketing efforts to attract a younger demographic, aiming for a 20% increase in engagement[182]. - New product launches are expected to contribute an additional 300 million RMB in revenue, with a focus on health-related technologies[182]. - Investment in research and development has increased by 30%, focusing on innovative health solutions[182]. Financial Position and Capital Management - The company requires approximately 800 million RMB in working capital for its 2017 operations, facing significant financial pressure[90]. - The company has not engaged in any major contracts that generated profits exceeding 10% of the total profit for the reporting period[134]. - The company has not engaged in any entrusted financial management or loans during the reporting period[141][142]. - The company has not issued any social responsibility reports during the reporting period[148].
中基健康(000972) - 2016 Q3 - 季度财报
2016-10-28 16:00
Financial Performance - Operating revenue for the reporting period was ¥138,407,183.03, down 4.39% year-on-year, and total revenue for the year-to-date was ¥311,646,857.50, a decrease of 21.04%[8] - The net profit attributable to shareholders of the listed company was a loss of ¥36,535,006.88 for the reporting period, with a year-to-date loss of ¥91,255,014.13[8] - Basic and diluted earnings per share were both -¥0.0474 for the reporting period[8] - The weighted average return on net assets was -3.60%, an increase of 1.41 percentage points compared to the previous year[8] - The company does not anticipate significant changes in net profit for the fiscal year compared to the previous year[28] Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,667,952,923.79, an increase of 1.45% compared to the previous year-end[8] - Net assets attributable to shareholders of the listed company decreased by 8.47% to ¥995,386,189.95[8] - Cash and cash equivalents decreased by 58.33% to ¥139,575,998.03 due to payments for outstanding raw material costs[17] - Inventory increased by 53.71% to ¥902,873,709.27 as timely payments for raw materials were made during the production period[17] - Prepayments rose by 149.52% to ¥39,114,922.54, primarily for packaging materials[17] Cash Flow - The company reported a net cash flow from operating activities of -¥262,633,653.82 year-to-date[8] - Cash received from operating activities decreased by 53.33% to ¥51,914,789.67, primarily due to a reduction in receivables[18] - Cash paid for purchasing goods and services increased by 31.07% to ¥525,180,250.62, reflecting higher procurement costs[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 66,002[11] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of shares, totaling 119,243,804 shares[12] Legal Matters - The company is involved in ongoing litigation related to investor claims, with a total claim amount of approximately ¥21,249,617.19[19] - The company has incurred a direct economic loss of CNY 6,183,333.33 due to a contract violation by Mastercard, resulting in a 7-month delay in receiving goods[25] - As of the report date, the lawsuit against Mastercard has not progressed, with the company having filed a request with the Tianjin Second Intermediate People's Court[25] - The company has received multiple announcements regarding litigation matters, including updates on investor lawsuits as of August 4, August 20, and September 27, 2016[26] Operational Insights - Management expenses increased by 46.18% to ¥50,484,844.56 due to changes in consolidation scope and increased employee count[17] - Financial expenses rose by 42.13% to ¥19,239,579.95, mainly due to exchange rate fluctuations[17] - The company received a total of ¥166,980,000.00 in borrowings, a decrease of 42.54% compared to the previous period[18] - The company holds 301,600 shares of Beixin Road and Bridge, with a book value of CNY 2,602,808 and a loss of CNY 799,240 during the reporting period[28] - There were no derivative investments during the reporting period[29] - The company received over 150 phone inquiries and responded to more than 90 written inquiries from investors regarding production operations and major asset restructuring[30] - There were no instances of non-compliant external guarantees during the reporting period[31] - The company reported no non-operating fund occupation by controlling shareholders or related parties[32]